South Korea · Delayed Price · Currency is KRW PeopleBio Statistics
Total Valuation
PeopleBio has a market cap or net worth of KRW 13.61 billion. The enterprise value is 24.03 billion.
| Market Cap | 13.61B |
| Enterprise Value | 24.03B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PeopleBio has 24.26 million shares outstanding. The number of shares has increased by 3.83% in one year.
| Current Share Class | 24.26M |
| Shares Outstanding | 24.26M |
| Shares Change (YoY) | +3.83% |
| Shares Change (QoQ) | -9.81% |
| Owned by Insiders (%) | 8.90% |
| Owned by Institutions (%) | n/a |
| Float | 19.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.55 |
| PB Ratio | 0.47 |
| P/TBV Ratio | 0.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.26 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.04, with a Debt / Equity ratio of 2.65.
| Current Ratio | 0.04 |
| Quick Ratio | 0.02 |
| Debt / Equity | 2.65 |
| Debt / EBITDA | n/a |
| Debt / FCF | -7.70 |
| Interest Coverage | -2.83 |
Financial Efficiency
Return on equity (ROE) is -79.69% and return on invested capital (ROIC) is -11.36%.
| Return on Equity (ROE) | -79.69% |
| Return on Assets (ROA) | -10.14% |
| Return on Invested Capital (ROIC) | -11.36% |
| Return on Capital Employed (ROCE) | -34.80% |
| Weighted Average Cost of Capital (WACC) | 4.51% |
| Revenue Per Employee | 147.58M |
| Profits Per Employee | -604.70M |
| Employee Count | 26 |
| Asset Turnover | 0.06 |
| Inventory Turnover | 1.49 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -76.82% in the last 52 weeks. The beta is 0.63, so PeopleBio's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | -76.82% |
| 50-Day Moving Average | 889.18 |
| 200-Day Moving Average | 1,166.12 |
| Relative Strength Index (RSI) | 34.53 |
| Average Volume (20 Days) | 584,788 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PeopleBio had revenue of KRW 3.84 billion and -15.72 billion in losses. Loss per share was -696.76.
| Revenue | 3.84B |
| Gross Profit | 702.53M |
| Operating Income | -10.77B |
| Pretax Income | -12.66B |
| Net Income | -15.72B |
| EBITDA | -9.81B |
| EBIT | -10.77B |
| Loss Per Share | -696.76 |
Balance Sheet
The company has 301.83 million in cash and 76.49 billion in debt, with a net cash position of -76.19 billion or -3,140.17 per share.
| Cash & Cash Equivalents | 301.83M |
| Total Debt | 76.49B |
| Net Cash | -76.19B |
| Net Cash Per Share | -3,140.17 |
| Equity (Book Value) | 28.82B |
| Book Value Per Share | 1,151.11 |
| Working Capital | -75.85B |
Cash Flow
In the last 12 months, operating cash flow was -4.98 billion and capital expenditures -4.95 billion, giving a free cash flow of -9.93 billion.
| Operating Cash Flow | -4.98B |
| Capital Expenditures | -4.95B |
| Depreciation & Amortization | 957.87M |
| Net Borrowing | 508.86M |
| Free Cash Flow | -9.93B |
| FCF Per Share | -409.28 |
Margins
| Gross Margin | 18.31% |
| Operating Margin | -280.71% |
| Pretax Margin | -330.04% |
| Profit Margin | n/a |
| EBITDA Margin | -255.74% |
| EBIT Margin | -280.71% |
| FCF Margin | n/a |
Dividends & Yields
PeopleBio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.83% |
| Shareholder Yield | -3.83% |
| Earnings Yield | -115.51% |
| FCF Yield | -72.96% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 23, 2023. It was a forward split with a ratio of 1.2.
| Last Split Date | Oct 23, 2023 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
PeopleBio has an Altman Z-Score of -2.14 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.14 |
| Piotroski F-Score | 2 |